Claude discovers CRISPR-like ART enzyme system in phages
Anthropic announced that Claude discovered a new enzyme system called ART in phage DNA, featuring reverse transcriptase, a partner gene, and repeated DNA arrays reminiscent of CRISPR. The system's arrays are transcribed into distinct short RNAs, suggesting potential programmability. The discovery was led by Claude agents over 21 hours analyzing 200k+ reverse transcriptases.
Key insights
Discovery of ART System
Claude identified a previously unnoticed enzyme system in bacteriophage DNA named ART (Array-associated Reverse Transcriptase). It consists of a reverse transcriptase, an unknown partner gene, and a long array of equally spaced repetitive DNA sequences, structurally similar to CRISPR arrays. The arrays are transcribed into distinct short RNAs, hinting at a programmable mechanism.
Potential Gene Editing Tool
Only a few systems with these characteristics have been found previously, and all are capable of cutting, copying, or editing DNA. CRISPR is already used in gene therapy; others are being developed as tools. Anthropic suggests ART could become a new gene editing mechanism, though its exact function remains unknown.
AI-Driven Discovery Process
The discovery was made almost entirely by Claude. Researchers gave an initial prompt to search for interesting new reverse transcriptases. About 950 Claude agents ran for 21 hours consuming 210M tokens, filtering from 200k+ reverse transcriptases to 3,500 candidates, then the top 20 were written into human-readable reports. One agent recognized the repetitive array in the raw sequence.
Expert Endorsement
CRISPR pioneer Feng Zhang reviewed the preprint and commented that this is a good example of AI agents participating in biological discovery, and that such arrays deserve further study. Dario Amodei noted the exponential trend in AI for biology similar to mathematics, but requiring experimental verification.
Anthropic's Life Sciences Lab
Anthropic's life sciences team, established in spring 2026, has its own wet lab for BSL-1 and BSL-2 research. All experiments were performed by human scientists. The team uses publicly available Claude Science and Claude Code, meaning other labs could replicate the AI-assisted discovery process.
Broader Implications for Biology
Dario Amodei wrote that AI's utility in biology is not limited by the need for experiments; humans and AI can collaborate to validate results in weeks. Eventually, Claude might autonomously control lab equipment. Biomedical advancement has many stages, and accelerating fundamental discovery can speed up the entire pipeline.
Relation to Prior Work
ART joins a line of prior work including CRISPR, bridge recombinase, VIPR, and recently described RT systems from a Stanford team. Anthropic believes we are at the very beginning of finding such systems and developing them into powerful biotechnologies. The company aims to grow its life sciences team and collaborate with external scientists.